Hancock Modified Orifice Bioprosthesis
PMA P790007
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP790007 | Date30 May 1985 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- heart-valve, non-allograft tissue
- PMA Number
- FDA Product Code
- LWR
- Device Class
- Class III
- Advisory Committee
- Cardiovascular
- FDA Decision
- APPR Approved
- PMA Supplement
- S007
Overview
AI-generated summary, 18 Sep 2026
The Hancock Modified Orifice Bioprosthesis is a heart-valve, non-allograft tissue device. It is designed for use as a prosthetic heart valve to replace diseased or damaged native valves.
This device received FDA PMA approval (P790007) on March 6, 1980, and is manufactured by Medtronic Heart Valves in Santa Ana, CA. It is classified as a Class III device under product code LWR.
Other devices from Medtronic Heart Valves
Questions
AI-generated answers, 18 Sep 2026
What type of device is the Hancock Modified Orifice Bioprosthesis?
The Hancock Modified Orifice Bioprosthesis is a heart-valve, non-allograft tissue device, as defined in the specifications under generic_name and openfda device_name.
Who manufactures the Hancock Modified Orifice Bioprosthesis?
The device is manufactured by Medtronic Heart Valves, as stated in both the MANUFACTURER and applicant fields in the device data.
What regulatory authorization does the Hancock Modified Orifice Bioprosthesis have?
The device has FDA PMA authorization, with PMA number P790007 and decision date March 6, 1980, as shown in the AUTHORIZATIONS and pma_number fields.